Bolloré Logistics China gains IATA CEIV pharma certification


Bolloré Logistics China has been awarded IATA CEIV pharma certification at its platform in the Shanghai Pudong International Airport Logistics Park.

It is one of the first transport and logistics companies in China to receive the certification.

The certification means that Bolloré Logistics China fully conforms to all applicable pharmaceutical standards expected from pharmaceutical manufacturers in terms of facilities, equipment, operations and staff and being capable to provide seamless cool chain transportation all along the supply chain.

The CEIV certification will allow Bolloré Logistics China to have a strategic advantage in the China healthcare logistics market with a stronger, more competitive and enhanced air cargo service.

With Singapore, Australia, South Korea and now China certified, the aim of Bolloré Logistics is to obtain certification throughout its global network, with Hong Kong and Japan next on the list in Asia Pacific.

In Europe, Bolloré Logistics has already received the certification for its Paris Roissy CDG platform (France) as well as its sites in Brussels (Belgium), Frankfurt (Germany) and Lisbon (Portugal).

IATA created CEIV certification in 2015. It aims to set the industrial standard for air cargo supply chain in pharmaceutical handling excellence. It aims to address the industry’s need for more safety, security, compliance and efficiency, by the creation of a globally consistent and recognised pharmaceutical product handling certification. CEIV Pharma encompasses, or even supersedes, many existing pharmaceutical standards and guidelines, such as IATA Temperature Control Regulations (TCR), European Union Good Distribution Practices (EU GDP), World Health Organization Annex 5 and United States Pharmacopeia Standards.

Source: Bolloré Logistics

GSCi

The world's largest collection of global supply chain intelligence

  • quickly and easily search and gain invaluable insight into the logistics industry
  • Empower everyone from business development executives to CEO level
  • Enhance the role of the market research department